Benefit of adjuvant chemotherapy in lymph node-negative, T1b and T1c triple-negative breast cancer.

Walter Carbajal-OchoaDaniela C Bravo-SolarteAna M BernalJesus D Anampa

Published in: Breast cancer research and treatment (2023)

Our study results support the use of adjuvant chemotherapy in patients with node-negative, T1c TNBC. Patients with node-negative, T1b TNBC had excellent long-term outcomes; furthermore, chemotherapy was not associated with improved BCSS in these patients.

Keyphrases

lymph node
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
neoadjuvant chemotherapy
prognostic factors
peritoneal dialysis
patient reported